All In Biotech

Drug Trial Radar · NCT07285070

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

A Phase 2, Randomized, Double-Masked, Controlled, Proof-of-Concept Study to Evaluate the Safety and Biological Activity of a Water-free Tacrolimus Ophthalmic Solution (NOV05) for the Treatment of Non-Infectious Anterior Uveitis

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Mar 16, 2026

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Novaliq GmbHIndustry
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.

Conditions

  • Non-infectious Anterior Uveitis

Interventions

  • Tacrolimus ophthalmic solutionDrug

    high and low dose treatment will be compared over 6 weeks treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventsTime frame: 8 weeks

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Horizon Eye & Lasik Center

    Phoenix, Arizona

  • Bascom Palmer Eye Institute

    Miami, Florida

  • Massachusetts Eye Research and Surgery Institution

    Waltham, Massachusetts

  • Metropolitan Eye Research and Surgery Institute

    Palisades Park, New Jersey

  • Valley Retina Institute, P.A.

    McAllen, Texas

  • Virginia Eye Consultants

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.